Sort
51,593 grants matching “hepatitis”
Understanding and Improving the Effectiveness of Public Health Laboratory Networks for Infectious Diseases in Ghana
$631,451Lee Frederick Schroeder · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH
$631,451Kenneth Cusi · University Of Florida · R01 · FY2020 · DK
Role of Tim-l in B Cells in regulating autoimmunity in the CNS
$631,364Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2025 · AI
Role of Tim-l in B Cells in regulating autoimmunity in the CNS
$631,364Vijay K Kuchroo · Brigham And Women'S Hospital · R01 · FY2024 · AI
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$631,218Shruti H Mehta · Johns Hopkins University · R01 · FY2010 · DA
Alcohol Research Consortium in HIV: Implementation Research Arm
$631,197Geetanjali Chander · Johns Hopkins University · P01 · FY2024 · AA
RBP2 Biology and Pathobiology
$631,164William S Blaner · Columbia University Health Sciences · R01 · FY2024 · DK
HIV, HCV, Hippo, and Liver Disease Progression
$631,145Raymond T Chung · Massachusetts General Hospital · R01 · FY2022 · AI
Identification and functional impact of NAFLD associated genetic variants
$631,099Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance
$631,073Gretchen Lano Birbeck · University Of Rochester · R01 · FY2018 · NS
Drug-gene-nutraceutical interactions of cannabidiol
$631,061Michael Thomas Eadon · Indiana University Indianapolis · R01 · FY2024 · AT
Understanding the underlying toxicological mechanisms of drug-hormone interactions to improve the safety profile of antiviral medications in pregnant people, developing fetuses, and neonates
$631,055Jed Noah Lampe · University Of Colorado Denver · R01 · FY2024 · AI
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA
$631,043Frederick Bradley Johnson · University Of Pennsylvania · R01 · FY2019 · HL
Next Generation of Recombinant AAV Serotype For Gene Therapy
$630,906Roland W. Herzog · University Of Florida · R01 · FY2015 · HL
Persistent hepatitis C virus replication and immunity in pregnancy
$630,820Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2020 · AI
Inflammation, Macrophage Differentiation, and Cancer
$630,814Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
STD and AIDS Research Training Grant
$630,765Sheila A. Lukehart · University Of Washington · T32 · FY2016 · AI
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis
$630,762Daniel James Rader · University Of Pennsylvania · R01 · FY2018 · DK
Models of AT Deficiency Using Human Hepatocytes
$630,750Ira J. Fox · Washington University · P01 · FY2019 · DK
IL-27R signaling as a negative regulator of innate and adaptive anti-cancer immunity in hepatocellular carcinoma
$630,729Ekaterina Koltsova · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
$630,691Renier Joseph Brentjens · Roswell Park Cancer Institute Corp · U01 · FY2023 · CA
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
$630,683Charles M. Rice · Rockefeller University · R01 · FY2022 · AI
IDENTIFICATION AND PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC APPROACHES TO DYSKERATOSIS CONGENITA
$630,648Frederick Bradley Johnson · University Of Pennsylvania · R01 · FY2020 · HL
HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants
$630,622Marianna K Baum · Florida International University · R01 · FY2009 · DA
A new hepatocyte-specific ligand for gene delivery
$630,582So C Wong · Mirus Bio Corporation · R44 · FY2007 · DK